Appendix Table 4.
Baseline | Follow-up | Absolute change | |
---|---|---|---|
Age | 64.65 years | ||
Disease duration (months) | 30.74 | ||
Global assessments | |||
Patient global assessment (0–10)* | 1 | 0 | −1 |
Physician global assessment (0–10)* | 7 | 4 | −3 |
Musculoskeletal | |||
HAQ-DI (0–3)* | 0.375 | 0.250 | −0.125 |
Tendon friction rubs* | No | No | No change |
Skin | |||
MRSS (0–51)* | 21 | 15 | −6 |
Patient skin interference last month | 8 | 5 | −3 |
Lung | |||
FVC% predicted* | 86 | 81 | −5 |
Breathing VAS (0–10) | 0 | 0 | 0 |
Renal | |||
Renal crisis** | Yes | Yes | No change |
Gastrointestinal | |||
GI VAS (0–10) | 0 | 0 | 0 |
Body Mass Index (BMI) | 25.12 | 24.82 | −0.3 |
Raynaud’s | |||
Raynaud’s VAS (0–10) | 3 | 4 | 1 |
Digital ulcers | |||
Digital ulcers VAS (0–10) | 0 | 8 | 8 |
Number of digital ulcers | 0 | 0 | 0 |
HRQOL | |||
Pain VAS (0–10) | 0 | 2 | 2 |
Fatigue (SF-36 Vitality scale) (0–100) | 35.12 | 35.12 | 0.0 |
included in Step 2;
included in Step 1
HAQ-DI= health assessment questionnaire-disability index, MRSS= modified Rodnan skin score, FVC= Forced vital capacity, GI= gastrointestinal, VAS= visual analog scale